Evaluation of the Effects os Losartan in Cardiovascular Disease Patient With Mucopolysaccharidoses IVA and VI
Conditions:   Mucopolysaccharidosis IV A;   Mucopolysaccharidosis VI;   Mucopolysaccharidoses Interventions:   Drug: Losartan;   Drug: Placebo Sponsors:   Hospital de Clinicas de Porto Alegre;   The Isaac Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2018 Category: Research Source Type: clinical trials

Mucopolysaccharidosis (MPS) Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia Combined With Pediatric ENT Surgery or Bronchoscopy
Condition:   Mucopolysaccharidoses Intervention:   Sponsors:   Mackay Memorial Hospital;   Sanofi Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2017 Category: Research Source Type: clinical trials

Mucopolysaccharidosis (MPS) Screening in ENT
Condition:   Mucopolysaccharidoses Intervention:   Sponsors:   Mackay Memorial Hospital;   Sanofi Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2017 Category: Research Source Type: clinical trials